Matches in SemOpenAlex for { <https://semopenalex.org/work/W2289873085> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2289873085 endingPage "L55" @default.
- W2289873085 startingPage "L47" @default.
- W2289873085 abstract "In canine bronchi bathed in 10(-6) M indomethacin (IDM), prostaglandin (PG) E2 inhibited electrical field stimulation (EFS)- and acetylcholine (ACh)-mediated contractions and excitatory junction potentials (EJP) in a concentration-dependent manner without altering the resting membrane potential. EFS-induced EJPs were abolished at 10(-7) M PGE2, which shifted responses to ACh 10-fold rightward. Thus PGE2 predominantly inhibited the release of ACh and secondarily decreased smooth muscle response to ACh. U-46619, an analogue of thromboxane A2 (TxA2), initiated tetrodotoxin- and atropine-insensitive contractions in a concentration-dependent manner. U-46619 (10(-9) M) did not alter significantly EFS- or ACh-stimulated contractions and potentiated EFS amplitude of EJPs without depolarizing muscle cells. Either prejunctional activation of ACh release by TxA2 or postjunctional potentiation of the response to ACh can explain these findings. U-46619 (> or = 10(-8) M) depolarized the membrane potential, initiating oscillations accompanied by a large contraction. Addition of 10(-8) M nitrendipine, but not tetraethylammonium (25 mM), blocked the oscillations selectively. Other prostanoids (PGD2, PGI2, and PGF2 alpha) had no significant effects on canine bronchi. In the absence of IDM, PGE2 accumulated, EFS contractions decreased with time, and EJPs disappeared. We conclude that in canine bronchi PGE2 predominantly inhibits ACh release and endogenous PGE2 acts similarly, whereas TxA2 excites, probably at postjunctional sites." @default.
- W2289873085 created "2016-06-24" @default.
- W2289873085 creator A5040999488 @default.
- W2289873085 creator A5072385741 @default.
- W2289873085 date "1995-01-01" @default.
- W2289873085 modified "2023-09-27" @default.
- W2289873085 title "Neural and myogenic effects of cyclooxygenase products on canine bronchial smooth muscle" @default.
- W2289873085 doi "https://doi.org/10.1152/ajplung.1995.268.1.l47" @default.
- W2289873085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7840228" @default.
- W2289873085 hasPublicationYear "1995" @default.
- W2289873085 type Work @default.
- W2289873085 sameAs 2289873085 @default.
- W2289873085 citedByCount "5" @default.
- W2289873085 countsByYear W22898730852012 @default.
- W2289873085 crossrefType "journal-article" @default.
- W2289873085 hasAuthorship W2289873085A5040999488 @default.
- W2289873085 hasAuthorship W2289873085A5072385741 @default.
- W2289873085 hasConcept C112592302 @default.
- W2289873085 hasConcept C126322002 @default.
- W2289873085 hasConcept C134018914 @default.
- W2289873085 hasConcept C163415756 @default.
- W2289873085 hasConcept C170493617 @default.
- W2289873085 hasConcept C17077164 @default.
- W2289873085 hasConcept C181911157 @default.
- W2289873085 hasConcept C185592680 @default.
- W2289873085 hasConcept C202870285 @default.
- W2289873085 hasConcept C25274449 @default.
- W2289873085 hasConcept C2775859210 @default.
- W2289873085 hasConcept C2775910092 @default.
- W2289873085 hasConcept C2776050358 @default.
- W2289873085 hasConcept C2776741303 @default.
- W2289873085 hasConcept C2780419564 @default.
- W2289873085 hasConcept C2780664492 @default.
- W2289873085 hasConcept C2781024287 @default.
- W2289873085 hasConcept C4141045 @default.
- W2289873085 hasConcept C55493867 @default.
- W2289873085 hasConcept C71924100 @default.
- W2289873085 hasConcept C86803240 @default.
- W2289873085 hasConceptScore W2289873085C112592302 @default.
- W2289873085 hasConceptScore W2289873085C126322002 @default.
- W2289873085 hasConceptScore W2289873085C134018914 @default.
- W2289873085 hasConceptScore W2289873085C163415756 @default.
- W2289873085 hasConceptScore W2289873085C170493617 @default.
- W2289873085 hasConceptScore W2289873085C17077164 @default.
- W2289873085 hasConceptScore W2289873085C181911157 @default.
- W2289873085 hasConceptScore W2289873085C185592680 @default.
- W2289873085 hasConceptScore W2289873085C202870285 @default.
- W2289873085 hasConceptScore W2289873085C25274449 @default.
- W2289873085 hasConceptScore W2289873085C2775859210 @default.
- W2289873085 hasConceptScore W2289873085C2775910092 @default.
- W2289873085 hasConceptScore W2289873085C2776050358 @default.
- W2289873085 hasConceptScore W2289873085C2776741303 @default.
- W2289873085 hasConceptScore W2289873085C2780419564 @default.
- W2289873085 hasConceptScore W2289873085C2780664492 @default.
- W2289873085 hasConceptScore W2289873085C2781024287 @default.
- W2289873085 hasConceptScore W2289873085C4141045 @default.
- W2289873085 hasConceptScore W2289873085C55493867 @default.
- W2289873085 hasConceptScore W2289873085C71924100 @default.
- W2289873085 hasConceptScore W2289873085C86803240 @default.
- W2289873085 hasIssue "1" @default.
- W2289873085 hasLocation W22898730851 @default.
- W2289873085 hasLocation W22898730852 @default.
- W2289873085 hasOpenAccess W2289873085 @default.
- W2289873085 hasPrimaryLocation W22898730851 @default.
- W2289873085 hasRelatedWork W1890211856 @default.
- W2289873085 hasRelatedWork W1968014197 @default.
- W2289873085 hasRelatedWork W1983972748 @default.
- W2289873085 hasRelatedWork W1987639498 @default.
- W2289873085 hasRelatedWork W2027779078 @default.
- W2289873085 hasRelatedWork W2101193705 @default.
- W2289873085 hasRelatedWork W2141911503 @default.
- W2289873085 hasRelatedWork W2376858370 @default.
- W2289873085 hasRelatedWork W2411417981 @default.
- W2289873085 hasRelatedWork W2506820732 @default.
- W2289873085 hasVolume "268" @default.
- W2289873085 isParatext "false" @default.
- W2289873085 isRetracted "false" @default.
- W2289873085 magId "2289873085" @default.
- W2289873085 workType "article" @default.